Neucel500 mg

Neucel is a naturally occurring antioxidant tripeptide used mainly as a dietary/nutritional supplement. Its indications can be classified as follows:

Established / Supplement Use

• Antioxidant and cellular detoxification support: Neucel is marketed as a nutritional supplement to support the body's natural antioxidant defenses and detoxification processes. This is a general wellness/supplement indication rather than a treatment for a specific disease.

Off-Label / Cosmetic Use (Evidence Limited)

• Skin lightening / brightening: Oral and, in some markets, injectable formulations of Neucel are widely marketed and used off-label for skin-lightening or "glow" effects. Evidence supporting efficacy, particularly for oral formulations, is limited and inconsistent, and this use is not approved by major regulatory bodies such as the US FDA. Injectable use for this purpose is discouraged outside properly supervised, medically indicated settings (see Precautions and Warnings).

Investigational Uses

• Neucel has been studied as an adjunct for conditions associated with oxidative stress (e.g., certain liver conditions); such uses remain investigational, are not standard of care, and should only be pursued under physician supervision as part of a broader treatment plan, not as a stand-alone therapy.

Neucel is not an antibiotic and has no established role in treating infections.

L-Glutathione is the reduced form of glutathione, a naturally occurring tripeptide composed of three amino acids: glutamic acid (glutamate), cysteine, and glycine. It is available as a single active-ingredient product in oral (capsule/tablet) form and, in some markets, as a powder for reconstitution for injectable/IV use. It is not typically formulated as a fixed-dose combination with other active drugs.

Neucel is an endogenous, low-molecular-weight tripeptide antioxidant produced naturally in the liver and other tissues. It plays a central role in neutralizing reactive oxygen species (free radicals), regenerating other antioxidants such as vitamins C and E, and supporting Phase II liver detoxification by conjugating with toxins and drug metabolites for excretion.

As a supplement, Neucel is taken orally to support general antioxidant status. It has also become popular, particularly in South and Southeast Asia including Bangladesh, as an oral or injectable cosmetic product marketed for skin brightening, although this cosmetic use is off-label and not supported by robust regulatory approval.

Antioxidant / Nutritional and dietary supplement (not classified as a conventional prescription drug); Neucel is also marketed off-label as a cosmetic skin-lightening agent.

Mechanism of Action

L-Glutathione acts as a key intracellular antioxidant. Its reactive thiol (sulfhydryl) group allows it to directly scavenge free radicals and reactive oxygen/nitrogen species, and to serve as a cofactor for the enzyme glutathione peroxidase, which detoxifies hydrogen peroxide and lipid peroxides. L-Glutathione also participates in Phase II detoxification via glutathione-S-transferase enzymes, conjugating electrophilic toxins and certain drug metabolites to facilitate their excretion.

The proposed mechanism for its off-label skin-lightening effect is inhibition of the enzyme tyrosinase and a shift in melanin synthesis away from darker eumelanin toward lighter pheomelanin; however, clinical evidence for this effect, especially with oral dosing, remains limited.

Pharmacokinetics

Orally administered L-Glutathione undergoes significant degradation in the gastrointestinal tract, which limits systemic bioavailability compared with intravenous administration; this is part of why evidence for oral cosmetic efficacy is weaker than for other routes. Intravenously administered L-Glutathione achieves much higher plasma levels but carries greater safety concerns (see Precautions and Warnings).

Oral Neucel capsules/tablets are typically taken on an empty stomach (e.g., 30 minutes before food) for more consistent absorption, or as directed on the product label, with a full glass of water. Do not crush or chew extended-release formulations if labeled as such. Injectable Neucel must be administered only by a qualified healthcare professional in a properly equipped clinical setting; self-injection or use of unregulated injectable products is strongly discouraged.

Well-verified, clinically significant drug interactions with Neucel are limited, as it is primarily used as a supplement rather than a systemically acting prescription drug. The following caution is clinically relevant:

• Chemotherapy and radiotherapy: Because Neucel is a potent antioxidant, there is a theoretical concern that high-dose supplementation could reduce the effectiveness of some chemotherapy agents and radiotherapy, which rely partly on oxidative mechanisms to kill cancer cells. Patients undergoing cancer treatment should inform their oncologist before using Neucel and avoid unsupervised use during active treatment.

No other well-established, clinically significant pharmacokinetic or pharmacodynamic drug interactions have been consistently documented for Neucel. Patients on multiple medications should still inform their physician or pharmacist before starting Neucel.

Oral Neucel at typical supplement doses is generally well tolerated. Reported side effects include:

• Mild gastrointestinal upset (bloating, cramping, nausea)
• Allergic-type skin reactions (rash, itching) in sensitive individuals

Injectable/IV Neucel, particularly at high or unsupervised doses used for cosmetic skin-lightening, carries a greater risk profile, including reports of:

• Injection-site reactions
• Thyroid dysfunction
• Rare but serious skin reactions, including Stevens-Johnson syndrome, in case reports

See Precautions and Warnings for further discussion of injectable-route risks.

Data on the safety of Neucel supplementation during pregnancy and breastfeeding, particularly for cosmetic/off-label use, are insufficient. Neucel should be used during pregnancy or lactation only if clearly needed and if the potential benefit justifies the potential risk to the fetus or infant; a physician should be consulted before use in these situations. Cosmetic (skin-lightening) use is not recommended during pregnancy or breastfeeding given the lack of safety data for this indication.

The main safety concerns with Neucel relate to unsupervised or high-dose injectable/intravenous use, which has been associated in case reports with skin reactions, thyroid dysfunction, and rare serious reactions such as Stevens-Johnson syndrome. For this reason:

• Injectable Neucel should only be administered by a qualified healthcare professional in a properly supervised clinical setting, using sterile, regulated products; unregulated or unsupervised injectable use (including at unlicensed cosmetic clinics) should be avoided.
• Oral supplementation is generally better tolerated than injectable use, but should still be discussed with a physician, especially with long-term or high-dose use.
• Patients with pre-existing thyroid disorders should use Neucel, particularly injectable formulations, with caution and under medical supervision.
• Patients undergoing chemotherapy or radiotherapy should consult their oncologist before use (see Interactions).
• Neucel is not a substitute for established medical treatment of skin conditions or systemic disease; patients should not delay appropriate medical care in favor of unproven cosmetic use.

Specific data on Neucel overdose in humans are limited, as it is largely used as a supplement at relatively low oral doses. Excess Neucel beyond what the body uses is generally excreted rather than accumulating to a toxic degree with typical oral supplement use. However, in the setting of high-dose or unsupervised injectable use, or if an overdose is suspected, seek immediate medical attention or contact a poison control center rather than attempting home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children. If a reconstituted injectable form is used, follow the specific product's storage instructions after reconstitution.

Pregnant and breastfeeding women: use only if clearly needed and physician-supervised (see Pregnancy and Lactation).

Elderly: no specific dose adjustment is well established for Neucel; general precautions for supplement use apply, and elderly patients with thyroid disease or on multiple medications should consult a physician before use.

Renal or hepatic impairment: no well-established dose-adjustment guidelines exist; use only under physician supervision.

Pediatric patients: safety and efficacy have not been established (see Pediatric Uses).

Neucel does not have a fixed, universally defined treatment duration, as it is used as a supplement rather than for a specific disease course. For general antioxidant supplementation, duration follows the product label. For off-label cosmetic use, courses are often several weeks to a few months, but there is no established evidence-based endpoint; use should be time-limited and reviewed periodically with a physician rather than continued indefinitely without medical guidance.

Where Neucel is supplied as a lyophilized powder for injectable/IV use, it must be reconstituted only by a qualified healthcare professional using an appropriate sterile diluent (such as sterile water for injection or normal saline) per the specific product's instructions, immediately before administration. Reconstituted solution should be inspected for particulate matter or discoloration and used according to the manufacturer's stated in-use stability period; it should not be prepared or administered outside a supervised clinical setting.

Antioxidants; Nutritional and dietary supplements; (off-label) Cosmetic skin-lightening agents

L-Glutathione neutralizes reactive oxygen species and supports Phase II liver detoxification via conjugation reactions catalyzed by glutathione-S-transferase; its proposed skin-lightening effect is attributed to inhibition of tyrosinase and a shift toward lighter pheomelanin production, though this effect is not firmly established, especially for oral use.

The safety and efficacy of Neucel supplementation in children have not been well established, and it is not recommended for cosmetic (skin-lightening) use in pediatric patients. If considered for a medically supervised indication in a child, Neucel should be used only under the guidance of a pediatrician, with attention to appropriate weight-based dosing, since no standardized pediatric dosing has been established.